Pelucchi Sara, Galimberti Stefania, Greni Federico, Rametta Raffaela, Mariani Raffaella, Pelloni Irene, Girelli Domenico, Busti Fabiana, Ravasi Giulia, Valsecchi Maria Grazia, Valenti Luca, Piperno Alberto
School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Centre of Biostatistics for Clinical Epidemiology, University of Milano-Bicocca, Monza, Italy.
J Gastroenterol Hepatol. 2016 Jul;31(7):1342-8. doi: 10.1111/jgh.13315.
p.Cys282Tyr homozygosity is the prevalent genotype in (HFE)-related Hereditary Hemochromatosis with low penetrance and variable expression. However, liver cirrhosis and hepatocellular carcinoma remain the main causes of mortality in these patients. Detection of genetic modifiers identifying patients at risk for liver damage would be relevant for their clinical management. We evaluated proprotein convertase 7 (PCSK7) rs236918 as genetic marker of risk of liver fibrosis in an Italian cohort of p.Cys282Tyr homozygotes.
Liver fibrosis was histologically assessed by Ishak score. We evaluated PCSK7 alleles and genotypes frequencies according to single or grouped staging scores: absent/mild fibrosis (stage: 0-2), moderate (stage: 3-4), and severe fibrosis/cirrhosis (stage: 5-6). Single nucleotide polymorphism genotyping was performed by restriction fragment length polymorphism or Taqman 5'-nuclease assays.
The rs236918 allele C frequency increased from stages 0-2 to 5-6 (7.1% vs 13.6%, vs 21.9%, P = 0.003). The wild-type genotype was significantly more frequent in the absent/mild fibrosis group (54.2%) compared with only 17% in patients with severe fibrosis/cirrhosis. At univariate proportional odds model, patients with GC + CC genotypes were 2.77 times (P = 0.0018) more likely to have worse liver staging scores than wild-type patients. In the adjusted analysis, odds ratio was 2.37 (P = 0.0218), and 2.56 (P = 0.0233) when the analysis was restricted to males. An exploratory mediation analysis suggested a direct effect of genotype on severe fibrosis/cirrhosis (odds ratio = 3.11, P = 0.0157), and a mild non-significant indirect effect mediated through iron accounting for 28%.
These findings confirm that PCSK7 rs236918 C allele is a risk factor for cirrhosis development in Italian patients with HFE-Hemochromatosis.
p.Cys282Tyr纯合子是(HFE)相关遗传性血色素沉着症中常见的基因型,其外显率低且表达可变。然而,肝硬化和肝细胞癌仍是这些患者的主要死亡原因。检测可识别肝损伤风险患者的基因修饰因子对其临床管理具有重要意义。我们在一组意大利p.Cys282Tyr纯合子队列中评估了前蛋白转化酶7(PCSK7)rs236918作为肝纤维化风险的遗传标志物。
通过Ishak评分对肝纤维化进行组织学评估。我们根据单一或分组分期评分评估PCSK7等位基因和基因型频率:无/轻度纤维化(分期:0 - 2)、中度(分期:3 - 4)和重度纤维化/肝硬化(分期:5 - 6)。通过限制性片段长度多态性或Taqman 5' - 核酸酶测定法进行单核苷酸多态性基因分型。
rs236918等位基因C的频率从0 - 2期到5 - 6期逐渐增加(7.1%对13.6%,对21.9%,P = 0.003)。野生型基因型在无/轻度纤维化组中显著更常见(54.2%),而在重度纤维化/肝硬化患者中仅为17%。在单变量比例优势模型中,GC + CC基因型患者出现更差肝分期评分的可能性是野生型患者的2.77倍(P = 0.0018)。在调整分析中,优势比为2.37(P = 0.0218),当分析仅限于男性时为2.56(P = 0.0233)。一项探索性中介分析表明基因型对重度纤维化/肝硬化有直接影响(优势比 = 3.11,P = 0.0157),并且通过铁介导的轻度非显著间接影响占28%。
这些发现证实PCSK7 rs236918 C等位基因是意大利HFE - 血色素沉着症患者肝硬化发展的危险因素。